-
EP2739735
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2739735
| EP2739735 - METHOD FOR IMPROVING THE SUCCESS RATE OF HEMATOPOIETIC STEM CELL TRANSPLANTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.07.2017 Database last updated on 09.09.2024 | |
| Former | Examination is in progress Status updated on 13.01.2017 | Most recent event Tooltip | 28.07.2017 | Application deemed to be withdrawn | published on 30.08.2017 [2017/35] | Applicant(s) | For all designated states Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142 / US | [2014/24] | Inventor(s) | 01 /
WONG, Jamie 300 Third Street Third Floor Cambridge Massachusetts 02142 / US | 02 /
BETTENCOURT, Brian 300 Third Street Third Floor Cambridge Massachusetts 02142 / US | [2014/24] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2014/24] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 12756579.4 | 01.08.2012 | WO2012US49156 | Priority number, date | US201161513820P | 01.08.2011 Original published format: US 201161513820 P | [2014/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013019857 | Date: | 07.02.2013 | Language: | EN | [2013/06] | Type: | A2 Application without search report | No.: | EP2739735 | Date: | 11.06.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.02.2013 takes the place of the publication of the European patent application. | [2014/24] | Search report(s) | International search report - published on: | EP | 06.06.2013 | Classification | IPC: | C12N15/113, A61K31/713, A61P7/00 | [2014/24] | CPC: |
C12N15/113 (EP,US);
C12N15/1136 (US);
A61K35/28 (US);
A61P35/02 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
C12N15/1137 (EP,US);
C12N15/1138 (EP,US);
C12N2310/14 (EP,US);
C12N2310/3515 (US);
C12N2320/00 (US);
C12N2320/30 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/24] | Title | German: | VERFAHREN ZUR VERBESSERUNG DER ERFOLGSQUOTE VON HÄMATOPOETISCHEN STAMMZELLENTRANSPLANTATEN | [2014/24] | English: | METHOD FOR IMPROVING THE SUCCESS RATE OF HEMATOPOIETIC STEM CELL TRANSPLANTS | [2014/24] | French: | PROCÉDÉ PERMETTANT D'AMÉLIORER LE TAUX DE SUCCÈS DES GREFFES DE CELLULES SOUCHES HÉMATOPOÏÉTIQUES | [2014/24] | Entry into regional phase | 29.01.2014 | National basic fee paid | 29.01.2014 | Designation fee(s) paid | 29.01.2014 | Examination fee paid | Examination procedure | 29.01.2014 | Examination requested [2014/24] | 15.09.2014 | Amendment by applicant (claims and/or description) | 07.09.2016 | Despatch of a communication from the examining division (Time limit: M06) | 18.03.2017 | Application deemed to be withdrawn, date of legal effect [2017/35] | 13.04.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/35] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.09.2016 | Fees paid | Renewal fee | 27.08.2014 | Renewal fee patent year 03 | 27.08.2015 | Renewal fee patent year 04 | 29.08.2016 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2001044415 (FRITZ LAWRENCE C [US], et al) [A] 1 * claim 8 * * claim - * * the whole document *; | [A]US2002147171 (FRITZ LAWRENCE C [US], et al) [A] 1 * claim 8 * * claim - * * the whole document *; | [A]WO2004014939 (UNIV WASHINGTON [US], et al) [A] 1 * claim 5 * * claim - * * the whole document *; | [A]WO2006006171 (GAMIDA CELL LTD [IL], et al) [A] 1 * the whole document *; | [A]WO2008133904 (STOWERS INST FOR MEDICAL RES [US], et al) [A] 1 * claim 5 * * page -; claim - * * the whole document *; | [A]WO2010059401 (IRM LLC, et al) [A] 1 * page 29 - page 32 * * the whole document *; | [A]WO2010085555 (GEN HOSPITAL CORP [US], et al) [A] 1 * claim - * * the whole document *; | [XI] - KUBO N. ET AL., "MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 403, no. 3-4, doi:10.1016/J.BBRC.2010.11.043, ISSN 0006-291X, (20101217), pages 405 - 411, (20101215), XP027561201 [X] 1,5,10,11,13-15,23,24,30-33 * the whole document * [I] 6-9,12,16-18,22,25-29 DOI: http://dx.doi.org/10.1016/j.bbrc.2010.11.043 | [XI] - S. K. SHENOY ET AL, "Nedd4 Mediates Agonist-dependent Ubiquitination, Lysosomal Targeting, and Degradation of the 2-Adrenergic Receptor", JOURNAL OF BIOLOGICAL CHEMISTRY, (20080101), vol. 283, no. 32, doi:10.1074/jbc.M709668200, ISSN 0021-9258, pages 22166 - 22176, XP055045072 [X] 1,5,10,11,13,23,24,30-33 * the whole document * [I] 6-9,12,14-18,22,25-29 DOI: http://dx.doi.org/10.1074/jbc.M709668200 | [XI] - HO K.C. ET AL., "Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20110322), vol. 108, no. 12, doi:10.1073/pnas.1101273108, ISSN 0027-8424, pages 4870 - 4875, XP055045037 [X] 1,23-25,28-33 * the whole document * [I] 26-29 DOI: http://dx.doi.org/10.1073/pnas.1101273108 | [X] - K. C. HO ET AL, "Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20110307), vol. 108, no. 12, doi:10.1073/pnas.1101273108, ISSN 0027-8424, XP055045039 [X] 1,23-25,28-33 * the whole document * * Supporting Information * DOI: http://dx.doi.org/10.1073/pnas.1101273108 | [XP] - DORJBAL B. ET AL., "The role of ITCH protein in Human T-cell Leukemia Virus Type 1 release", JOURNAL OF BIOLOGICAL CHEMISTRY, (20110909), vol. 286, no. 36, doi:10.1074/jbc.M111.259945, ISSN 0021-9258, pages 31092 - 31104, XP055045035 [XP] 1,23-25,28-33 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.M111.259945 | [X] - VARTANIAN R. ET AL., "AP-1 regulates Cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation", MOLECULAR CANCER RESEARCH, (20110101), vol. 9, no. 1, doi:10.1158/1541-7786.MCR-10-0105, ISSN 1541-7786, pages 115 - 130, XP055045042 [X] 1,23,24,30-33 * the whole document * DOI: http://dx.doi.org/10.1158/1541-7786.MCR-10-0105 | [X] - YANG F. ET AL., "Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells", CELL DEATH AND DIFFERENTIATION, (20100801), vol. 17, no. 8, doi:10.1038/cdd.2010.29, ISSN 1350-9047, pages 1354 - 1367, XP055045043 [X] 1,23,24,30-33 * the whole document * DOI: http://dx.doi.org/10.1038/cdd.2010.29 | [X] - A. PANNER ET AL, "Ubiquitin-Specific Protease 8 Links the PTEN-Akt-AIP4 Pathway to the Control of FLIPS Stability and TRAIL Sensitivity in Glioblastoma Multiforme", CANCER RESEARCH, (20100615), vol. 70, no. 12, doi:10.1158/0008-5472.CAN-09-3979, ISSN 0008-5472, pages 5046 - 5053, XP055045064 [X] 1,23,24,30-33 * the whole document * DOI: http://dx.doi.org/10.1158/0008-5472.CAN-09-3979 | [A] - SOREQ H. ET AL., "Antisense oligonucleotide inhibition of Acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (19940816), vol. 91, no. 17, doi:10.1073/pnas.91.17.7907, ISSN 0027-8424, pages 7907 - 7911, XP055044823 [A] 1 DOI: http://dx.doi.org/10.1073/pnas.91.17.7907 | [A] - G MELINO ET AL, "Itch: a HECT-type E3 ligase regulating immunity, skin and cancer", CELL DEATH AND DIFFERENTIATION, (20080701), vol. 15, no. 7, doi:10.1038/cdd.2008.60, ISSN 1350-9047, pages 1103 - 1112, XP055044983 [A] 1 * the whole document * DOI: http://dx.doi.org/10.1038/cdd.2008.60 | Examination | WO2006077407 | by applicant | US513030 | US564562 | US3687808 | US3753357 | US4199022 | US4426330 | US4469863 | US4476301 | US4534899 | US4559298 | US4587044 | US4605735 | US4657866 | US4667025 | WO8804924 | US4762779 | US4789737 | US4824941 | US4828979 | US4835263 | US4837028 | US4845205 | US4876335 | US4904582 | WO9004384 | US4948882 | US4958013 | US4981957 | US5004681 | WO9105545 | US5013556 | US5023243 | US5032401 | US5034506 | EP0445131 | US5082830 | US5109124 | US5112963 | US5114672 | US5118800 | US5118802 | US5134066 | EP0496813 | US5138045 | US5139941 | US5166315 | US5175273 | US5177195 | US5185444 | US5188897 | US5214134 | US5214136 | US5213804 | US5216141 | US5218105 | US5225212 | US5235033 | US5245022 | US5252479 | US5254469 | US5258506 | US5262536 | US5264423 | US5264564 | US5264221 | WO9324641 | US5272250 | US5276019 | US5278302 | WO9402595 | US5286717 | US5292873 | US5317098 | US5319080 | WO9412649 | US5321131 | WO9413788 | WO9420073 | US5356633 | US5359044 | US5367066 | US5371241 | US5391723 | US5393878 | US5397706 | US5399676 | US5405939 | US5405938 | US5414077 | US5416203 | US5432272 | US5434257 | US5436146 | US5446137 | US5451463 | US5453496 | US5455233 | US5457187 | US5459255 | US5466677 | US5466786 | US5470967 | US5476925 | US5484908 | US5486603 | US5489677 | US5502177 | WO9610391 | US5510475 | US5512439 | US5512667 | US5514785 | US5519126 | US5519134 | US5525711 | US5525465 | US5536821 | US5539082 | US5541316 | US5541307 | US5541313 | US5540935 | US5543152 | US5545730 | US5550111 | US5552540 | US5552538 | US5556948 | US5561225 | US5563253 | US5565552 | US5567811 | US5567810 | US5571799 | US5574142 | US5576427 | US5578717 | US5578718 | US5580731 | US5585481 | WO9640062 | WO9640964 | US5587361 | US5587469 | US5587371 | US5591722 | US5591584 | US5594121 | US5596086 | US5596091 | US5595726 | US5597909 | US5597696 | US5599923 | US5599928 | US5602240 | WO9704787 | US5607677 | US5608046 | US5610289 | US5610300 | US5614617 | US5618704 | WO9713499 | US5623070 | US5625050 | US5627053 | US5633360 | US5639873 | US5646265 | US5658873 | WO9730731 | US5663312 | US5665557 | US5665710 | US5670633 | US5677136 | US5677437 | US5677439 | US5681941 | US5688941 | US5700920 | US5705188 | US5714331 | US5719262 | US5750692 | US5766951 | US5908782 | US5976567 | US5981276 | US5981501 | US6015886 | WO0003683 | US6028188 | US6037174 | WO0022113 | WO0022114 | US6054299 | US6124445 | US6143520 | US6147200 | US6160109 | US6166197 | US6169170 | US6172209 | US6191105 | US6222025 | US6224860 | US6226997 | US6235887 | US6239265 | US6268490 | US6277603 | US6294664 | US6320017 | US6326199 | US6346614 | US6372210 | US6380368 | US6444423 | US2003027780 | US2003032179 | US6528640 | US6531590 | US6534639 | US6534484 | WO03042405 | US6576752 | US6586410 | US6608035 | US6617161 | US6617159 | US6617438 | US6639062 | US6670461 | US6683167 | US6747014 | US6783931 | US6794499 | US6815432 | US6852534 | US6858715 | US6867294 | US6878805 | US6887906 | US6900297 | US2005281781 | US6998484 | US2006040389 | US7015037 | US7015315 | US7037721 | US7037646 | US7041816 | US7045610 | US7053207 | US7063860 | US7070802 | US7084125 | US7109032 | US2006240093 | US7131958 | US7147626 | US7157099 | US7160714 | USRE39464E | US7169610 | US7179643 | US2007048313 | US2007135372 | US7273933 | US7321029 | US2008051332 | US7399845 | US7427672 | US7427605 | US7495088 | WO2009082817 | US2010324109 | - GLUCKMAN, E. ET AL., NEJM, (1997), vol. 337, pages 373 - 381 | - BARKER, J.N. ET AL., BB&MT, (2002), vol. 8, pages 257 - 260 | - LIAO, Y. ET AL., EXPERIMENTAL HEMATOLOGY, (2011), vol. 39, pages 393 - 412 | - THOMSON ET AL., SCI., (1998), vol. 282, pages 1145 - 47 | - VOGEL; HOLDEN, SCI, (2007), vol. 23, pages 1224 - 25 | - NAKAHATA; OGAWA, J. CLIN. INVEST., (1982), vol. 70, pages 1324 - 28 | - PRINDULL ET AL., ACTA. PAEDIATR. SCAND., (1978), vol. 67, pages 413 - 16 | - TCHERNIA ET AL., J. LAB. CLIN. MED., (1981), vol. 97, no. 3, pages 322 - 31 | - SIRCHIA; REBULLA, HAEMATOLOGICA, (1999), vol. 84, pages 738 - 47 | - LAUGHLIN, BONE MARROW TRANSPLANT., (2001), vol. 27, pages 1 - 6 | - SALAHUDDIN ET AL., BLOOD, (1981), pages 931 - 38 | - CAPPELLINI ET AL., BRIT. J. HAEMATOL., (1984), vol. 57, pages 61 - 70 | - DAFFOS ET AL., AM. J. OBSTET. GYNECOL., (1985), vol. 153, pages 655 - 60 | - DAFFOS ET AL., AM. J. OBSTET. GYNECOL., (1983), vol. 146, pages 985 - 87 | - VALENTI, AM. J. OBSTET. GYNECOL., (1973), vol. 115, pages 851 - 53 | - CAO ET AL., J. MED. GENET., (1982), vol. 19, pages 81 - 87 | - ALSEVER; AINSLIE, N. Y. ST. J. MED., (1941), vol. 41, pages 126 - 35 | - DEGOWIN ET AL., JAMA, (1940), vol. 114, pages 850 - 55 | - SMITH ET AL., J. THORAC. CARDIOVASC. SURG., (1959), vol. 38, pages 573 - 85 | - ROUS; TURNER, J. EXP. MED., (1916), vol. 23, pages 219 - 37 | - HURN, Storage of Blood, ACAD. PRESS, (1968), pages 26 - 160 | - LOVELOCK; BISHOP, NATURE, (1959), vol. 183, pages 1394 - 95 | - ASHWOOD-SMITH, NATURE, (1961), vol. 190, pages 1204 - 05 | - RINFRET, ANN. N.Y. ACAD. SCI., (1960), vol. 85, pages 576 - 94 | - SLOVITER; RAVDIN, NATURE, (1962), vol. 196, pages 899 - 900 | - ROW, CRYOBIOLOGY, (1966), vol. 3, no. 1, pages 12 - 18 | - BENDER ET AL., J. APPL. PHYSIOL., (1960), vol. 15, pages 520 - 24 | - PHAN; BENDER, EXP. CELL RES., (1960), vol. 20, pages 651 - 54 | - LOVELOCK, BIOCHEM. J., (1954), vol. 56, pages 265 - 70 | - PHAN; BENDER, PROC. SOC. EXP. BIOL. MED., (1960), vol. 104 | - RAPATZ, CRYOBIOLOGY, (1968), vol. 5, pages 18 - 25 | - ROWE; RINFRET, BLOOD, (1962), vol. 20, pages 636 - 37 | - ROWE, CRYOBIOLOGY, (1966), vol. 3, pages 12 - 18 | - LEWIS ET AL., TRANSFUSION, (1967), vol. 7, pages 17 - 32 | - MAZUR, SCIENCE, (1970), vol. 168, pages 939 - 49 | - SPITZER, CANCER, (1980), vol. 45, pages 3075 - 85 | - STIFF ET AL., CRYOBIOLOGY, (1983), vol. 20, pages 17 - 24 | - KUCHLER; DOWDEN; HUTCHINSON; ROSS, BIOCHEM . METHS. CELL CULTURE & VIROLOGY, (1964), pages 18 - 19 | - EISEN, ET AL.,, Meths. Med. Res., YEAR BOOK MED. PUB., INC., (1964), vol. 10, pages 39 - 47 | - SOSA-PINEDA ET AL., NAT. GENET., (2000), vol. 25, pages 254 - 255 | - WIGLE ET AL., NAT. GENET., (1999), vol. 21, pages 318 - 322 | - WIGLE; OLIVER, CELL, (1999), vol. 98, pages 769 - 778 | - LENGLER; GRAW, BIOCHEM. BIOPHYS. RES. COMMUN., (2001), vol. 287, pages 372 - 376 | - YAMAMOTO ET AL., NEUROSCI., (2001), vol. 21, pages 9814 - 9823 | - LENGLER ET AL., NUCLEIC ACIDS RES., (2001), vol. 29, pages 515 - 526 | - C. Q. DOE ET AL., "The Prospero gene specifies cell fates in the Drosophila central nervous system", CELL, (1991), vol. 65, doi:doi:10.1016/0092-8674(91)90463-9, pages 451 - 464, XP023908348 DOI: http://dx.doi.org/10.1016/0092-8674(91)90463-9 | - B. HASSAN ET AL., "Prospero is a panneural transcription factor that modulates homeodomain protein activity", PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 10991 - 10996 | - T. COOK ET AL., "Distinction between color photoreceptor cell fates is controlled by Prospero in Drosophila", DEV. CELL, (2003), vol. 4, pages 853 - 864 | - T. R. BURGLIN, "A Caehorhabditis elegans homologue defines a novel domain", TRENDS BIOCHEM. SCI., (1994), vol. 19, doi:doi:10.1016/0968-0004(94)90035-3, pages 70 - 71, XP023552827 DOI: http://dx.doi.org/10.1016/0968-0004(94)90035-3 | - S. I. TOMAREV ET AL., "Characterization of the mouse Proxl gene", BIOCHEM. BIOPHYS. RES. COMMUN, (1998), vol. 248, pages 684 - 689 | - J. QIN ET AL., "Prospero-related homeobox (Proxl) is a corepressor of human liver receptor homolog- and suppresses the transcription of the cholesterol 7-alpha-hydroxylase gene", MOL. ENDOCRINOL., (2004), vol. 18, pages 2424 - 2439 | - M. K. DUNCAN ET AL., "Proxl is differentially localized during lens development", MECH. DEV., (2002), vol. 112, pages 195 - 198 | - J. T. WIGLE ET AL., "Proxl function is crucial for mouse lens-fibre elongation", NAT. GENET., (1999), vol. 21, pages 318 - 322 | - M. A. DYER ET AL., "Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina", NAT. GENET., (2003), vol. 34, pages 53 - 58 | - J. LENGLER ET AL., "Antagonistic action of six3 and proxl at the gamma-crystallin promoter", NUCLEIC ACIDS RES., (2001), vol. 29, pages 515 - 526 | - W. CUI ET AL., "Mafs, Proxl and Pax6 can regulate chicken beta Bl-crystallin gene expression", J. BIOL. CHEM., (2004), vol. 279, pages 11088 - 11095 | - J. T. WIGLE ET AL., "Proxl function is required for the development of the murine lymphatic system", CELL, (1999), vol. 98, doi:doi:10.1016/S0092-8674(00)81511-1, pages 769 - 778, XP002309908 DOI: http://dx.doi.org/10.1016/S0092-8674(00)81511-1 | - B. SOSA-PINEDA ET AL., "Hepatocyte migration during liver development requires Proxl", NAT. GENET., (2000), vol. 25, pages 254 - 255 | - Z. BURKE ET AL., "Proxl is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm", MECH. DEV., (2002), vol. 118, pages 147 - 155 | - J. DUDAS ET AL., "The homeobox transcription factor Proxl is highly conserved in embryonic hepatoblasts and in adult and transformed hepatocytes, but is absent from bile duct epithelium", ANAT. EMBRYOL., (2004), vol. 208, pages 359 - 366 | - Y. K. HONG ET AL., "Prox is a master control gene in the program specifying lymphatic endothelial cell fate", DEV. DYN., (2002), vol. 225, pages 351 - 357 | - J. T. WIGLE ET AL., "An essential role for Proxl in the induction of the lymphatic endothelial cell phenotype", EMBO. J, (2002), vol. 21, doi:doi:10.1093/emboj/21.7.1505, pages 1505 - 1513, XP002309907 DOI: http://dx.doi.org/10.1093/emboj/21.7.1505 | - T. V. PETROVA ET AL., "Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor", EMBO J., (2002), vol. 21, pages 4593 - 4599, XP002309905 | - J. WILTING ET AL., "The transcription factor Prox 1 is a marker for lymphatic endothelial cells in normal and diseased human tissues", FASEB J., (2002), vol. 16, pages 1271 - 1273 | - J. S. REIS-FILHO ET AL., "Lymphangiogenesis in tumors: what do we know?", MICROSC. RES. TECH., (2003), vol. 60, doi:doi:10.1002/jemt.10255, pages 171 - 180, XP008042352 DOI: http://dx.doi.org/10.1002/jemt.10255 | - I. VAN DER AUWERA ET AL., "Increased angiogenesis and lymphangiogenesis in inflammatory versus noninllammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification", CLIN. CANCER RES., (2004), vol. 10, pages 7965 - 7971 | - M. A. AL-RAWI ET AL., "Lymphangiogenesis and its role in cancer", HISTOL. HISTOPATHOL., (2005), vol. 20, pages 283 - 298 | - SAFE S, TOXICOL LETT, (2001), vol. 120, pages 1 - 7 | - POLAND ET AL., J BIOL CHEM, (1976), vol. 251, pages 4936 - 4946 | - REISZ-PORSZASZ ET AL., MOL CELL BIOL, (1994), vol. 14, pages 6075 - 6086 | - REISZ-PORSZASZ ET AL., MOL CELL BIOL, (1994), vol. 14, page 60756086 | - SAFE, TOXICOL LETT, (2001), vol. 120, pages 1 - 7 | - OHTAKE ET AL., NATURE, (2003), vol. 423, pages 545 - 550 | - ELBASHIR ET AL., EMBO, (2001), vol. 20, pages 6877 - 6888 | - BEAUCAGE, S.L. ET AL., Current protocols in nucleic acid chemistry, JOHN WILEY & SONS, INC. | - NIELSEN ET AL., SCIENCE, (1991), vol. 254, pages 1497 - 1500 | - MARTIN ET AL., HELV. CHIM. ACTA, (1995), vol. 78, pages 486 - 504 | - KROSCHWITZ, J. L,, The Concise Encyclopedia Of Polymer Science And Engineering, JOHN WILEY & SONS, (1990), pages 858 - 859 | - ENGLISCH ET AL., ANGEWANDTE CHEMIE, (1991), vol. 30, page 613 | - "Chapter 15,", SANGHVI, Y S., RNA Research and Applications, CRC PRESS, (1993), pages 289 - 302 | - SANGHVI, Y. S., CROOKE, S. T. AND LEBLEU, B.,, RNA Research and Applications, CRC PRESS, (1993), pages 276 - 278 | - ELMEN, J. ET AL., NUCLEIC ACIDS RESEARCH, (2005), vol. 33, no. 1, pages 439 - 447 | - MOOK, OR. ET AL., MOL CANC THER, (2007), vol. 6, no. 3, pages 833 - 843 | - GRUNWELLER, A. ET AL., NUCLEIC ACIDS RESEARCH, (2003), vol. 31, no. 12, pages 3185 - 3193 | - LETSINGER ET AL., PROC. NATL. ACID. SCI. USA, (1989), vol. 86, pages 6553 - 6556 | - MANOHARAN ET AL., BIORG. MED. CHEM. LET., (1994), vol. 4, pages 1053 - 1060 | - MANOHARAN ET AL., ANN. N.Y. ACAD. SCI., (1992), vol. 660, pages 306 - 309 | - MANOHARAN ET AL., BIORG. MED. CHEM. LET., (1993), vol. 3, pages 2765 - 2770 | - OBERHAUSER ET AL., NUCL. ACIDS RES., (1992), vol. 20, pages 533 - 538 | - SAISON-BEHMOARAS ET AL., EMBO J, (1991), vol. 10, pages 1111 - 1118 | - KABANOV ET AL., FEBS LETT., (1990), vol. 259, pages 327 - 330 | - SVINARCHUK ET AL., BIOCHIMIE, (1993), vol. 75, pages 49 - 54 | - MANOHARAN ET AL., TETRAHEDRON LETT., (1995), vol. 36, pages 3651 - 3654 | - SHEA ET AL., NUCL. ACIDS RES., (1990), vol. 18, pages 3777 - 3783 | - MANOHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, (1995), vol. 14, pages 969 - 973 | - MISHRA ET AL., BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1264, pages 229 - 237 | - CROOKE ET AL., J. PHANNACOL. EXP. THER., (1996), vol. 277, pages 923 - 937 | - LAM ET AL., NATURE, (1991), vol. 354, pages 82 - 84 | - ZITZMANN ET AL., CANCER RES., (2002), vol. 62, pages 5139 - 43 | - AOKI ET AL., CANCER GENE THERAPY, (2001), vol. 8, pages 783 - 787 | - HAUBNER ET AL., JOUR. NUCL. MED., (2001), vol. 42, pages 326 - 336 | - SIMEONI ET AL., NUCL. ACIDS RES., (2003), vol. 31, pages 2717 - 2724 | - KUBO, T. ET AL., BIOCHEM. BIOPHYS. RES. COMM., (2007), vol. 365, no. 1, pages 54 - 61 | - LETSINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 6553 | - MANOHARAN ET AL., BIOORG. MED. CHEM. LETT., (1994), vol. 4, page 1053 | - MANOHARAN ET AL., ANN. N.Y. ACAD. SCI., (1992), vol. 660, page 306 | - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1993), vol. 3, page 2765 | - OBERHAUSER ET AL., NUCL. ACIDS RES., (1992), vol. 20, page 533 | - SAISON-BEHMOARAS ET AL., EMBO J., (1991), vol. 10, page 111 | - KABANOV ET AL., FEBS LETT., (1990), vol. 259, page 327 | - SVINARCHUK ET AL., BIOCHIMIE, (1993), vol. 75, page 49 | - MANOHARAN ET AL., TETRAHEDRON LETT., (1995), vol. 36, page 3651 | - SHEA ET AL., NUCL. ACIDS RES., (1990), vol. 18, page 3777 | - MANOHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, (1995), vol. 14, page 969 | - MISHRA ET AL., BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1264, page 229 | - CROOKE ET AL., J. PHARMACOL. EXP. THER., (1996), vol. 277, page 923 | - AKHTAR S.; JULIAN RL., TRENDS CELL. BIOL., (1992), vol. 2, no. 5, pages 139 - 144 | - TOLENTINO, MJ. ET AL., RETINA, (2004), vol. 24, pages 132 - 138 | - REICH, SJ. ET AL., MOL. VIS., (2003), vol. 9, pages 210 - 216 | - PILLE, J. ET AL., MOL. THER., (2005), vol. 11, pages 267 - 274 | - KIM, WJ. ET AL., MOL. THER., (2006), vol. 14, pages 343 - 350 | - LI, S. ET AL., MOL. THER., (2007), vol. 15, pages 515 - 523 | - DORN, G. ET AL., NUCLEIC ACIDS, (2004), vol. 32, page E49 | - TAN, PH. ET AL., GENE THER., (2005), vol. 12, pages 59 - 66 | - MAKIMURA, H. ET AL., BMC NEUROSCI., (2002), vol. 3, page 18 | - SHISHKINA, GT. ET AL., NEUROSCIENCE, (2004), vol. 129, pages 521 - 528 | - THAKKER, ER. ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2004), vol. 101, pages 17270 - 17275 | - AKANEYA,Y. ET AL., J. NEUROPHYSIOL., (2005), vol. 93, pages 594 - 602 | - HOWARD, KA. ET AL., MOL. THER., (2006), vol. 14, pages 476 - 484 | - ZHANG, X. ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 10677 - 10684 | - BITKO, V. ET AL., NAT. MED., (2005), vol. 11, pages 50 - 55 | - SOUTSCHEK, J. ET AL., NATURE, (2004), vol. 432, pages 173 - 178 | - MCNAMARA, JO. ET AL., NAT. BIOTECHNOL., (2006), vol. 24, pages 1005 - 1015 | - KIM SH. ET AL., JOURNAL OF CONTROLLED RELEASE, (2008), vol. 129, no. 2, pages 107 - 116 | - SORENSEN, DR. ET AL., J. MOL. BIOL, (2003), vol. 327, pages 761 - 766 | - VERMA, UN. ET AL., CLIN. CANCER RES., (2003), vol. 9, pages 1291 - 1300 | - ARNOLD, AS ET AL., J. HYPERTENS, (2007), vol. 25, pages 197 - 205 | - ZIMMERMANN, TS. ET AL., NATURE, (2006), vol. 441, pages 111 - 114 | - CHIEN, PY. ET AL., CANCER GENE THER., (2005), vol. 12, pages 321 - 328 | - PAL, A. ET AL., INT J. ONCOL., (2005), vol. 26, pages 1087 - 1091 | - AIGNER, A., J. BIOMED. BIOTECHNOL., (2006), page 71659 | - LIU, S., MOL. PHANN., (2006), vol. 3, pages 472 - 487 | - TOMALIA, DA. ET AL., BIOCHEM. SOC. TRANS., (2007), vol. 35, pages 61 - 67 | - YOO, H. ET AL., PHANN. RES., (1999), vol. 16, pages 1799 - 1804 | - COUTURE, A ET AL., TIG, (1996), vol. 12, pages 5 - 10 | - GASSMANN ET AL., PROC. NATL. ACAD. SCI. USA, (1995), vol. 92, page 1292 | - DOCHERTY ET AL., FASEB J., (1994), vol. 8, pages 20 - 24 | - MILLER ET AL., METH. ENZYMOL., (1993), vol. 217, pages 581 - 599 | - BOESEN ET AL., BIOTHERAPY, (1994), vol. 6, pages 291 - 302 | - CLOWES ET AL., J. CLIN. INVEST., (1994), vol. 93, pages 644 - 651 | - KIEM ET AL., BLOOD, (1994), vol. 83, pages 1467 - 1473 | - SALMONS; GUNZBERG, HUMAN GENE THERAPY, (1993), vol. 4, pages 129 - 141 | - GROSSMAN; WILSON, CURR. OPIN. IN GENETICS AND DEVEL., (1993), vol. 3, pages 110 - 114 | - KOZARSKY; WILSON, CURRENT OPINION IN GENETICS AND DEVELOPMENT, (1993), vol. 3, pages 499 - 503 | - BOUT ET AL., HUMAN GENE THERAPY, (1994), vol. 5, pages 3 - 10 | - ROSENFELD ET AL., SCIENCE, (1991), vol. 252, pages 431 - 434 | - ROSENFELD ET AL., CELL, (1992), vol. 68, pages 143 - 155 | - MASTRANGELI ET AL., J. CLIN. INVEST., (1993), vol. 91, pages 225 - 234 | - WANG ET AL., GENE THERAPY, (1995), vol. 2, pages 775 - 783 | - XIA H ET AL., NAT. BIOTECH., (2002), vol. 20, pages 1006 - 1010 | - WALSH ET AL., PROC. SOC. EXP. BIOL. MED., (1993), vol. 204, pages 289 - 300 | - SAMULSKI R ET AL., J. VIROL., (1987), vol. 61, pages 3096 - 3101 | - FISHER K J ET AL., J. VIROL, (1996), vol. 70, pages 520 - 532 | - SAMULSKI R ET AL., J. VIROL., (1989), vol. 63, pages 3822 - 3826 | - RABINOWITZ J E ET AL., J VIROL, (2002), vol. 76, pages 791 - 801 | - LIEBERMAN, RIEGER AND BANKER, Pharmaceutical Dosage Fonns, MARCEL DEKKER, INC., (1988), vol. 1, page 245 | - WANG ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1987), vol. 147, pages 980 - 985 | - ZHOU ET AL., JOURNAL OF CONTROLLED RELEASE, (1992), vol. 19, pages 269 - 274 | - WEINER ET AL., JOURNAL OF DRUG TARGETING, (1992), vol. 2, pages 405 - 410 | - DU PLESSIS ET AL., ANTIVIRAL RESEARCH, (1992), vol. 18, pages 259 - 265 | - HU ET AL., S.T.P.PHANNA. SCI., (1994), vol. 4, no. 6, page 466 | - ALLEN ET AL., FEBS LETTERS, (1987), vol. 223, page 42 | - WU ET AL., CANCER RESEARCH, (1993), vol. 53, page 3765 | - PAPAHADJOPOULOS ET AL., ANN. N.Y. ACAD. SCI., (1987), vol. 507, page 64 | - GABIZON ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, page 6949 | - SUNAMOTO, BULL. CHEM. SOC. JPN., (1980), vol. 53, page 2778 | - ILLUM ET AL., FEBS LETT., (1984), vol. 167, page 79 | - KLIBANOV ET AL., FEBS LETT., (1990), vol. 268, page 235 | - BLUME ET AL., BIOCHIMICA ET BIOPHYSICA ACTA, (1990), vol. 1029, page 91 | - RIEGER, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), page 285 | - LIEBENNAN, RIEGER AND BANKER, Phannaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 199 | - LIEBENNAN, RIEGER AND BANKER, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 245 | - LIEBENNAN, RIEGER AND BANKER, Block in Phannaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 2, page 335 | - HIGUCHI ET AL., Remington's Pharmaceutical Sciences, MACK PUBLISHING CO., (1985), page 301 | - RIEGER, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 285 | - IDSON, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 199 | - RIEGER, Pharmaceutical Dosage Forms, Lieberman, MARCEL DEKKER, INC., (1988), vol. 1, page 285 | - BLOCK, Pharmaceutical Dosage Forms, MARCEL DEKKER, INC., (1988), vol. 1, page 335 | - LEUNG; SHAH, Controlled Release of Drugs: Polymers and Aggregate Systems, VCH PUBLISHERS, (1989), pages 185 - 215 | - SCHOTT, Remington's Pharmaceutical Sciences, MACK PUBLISHING CO., (1985), page 271 | - BLOCK, Pharmaceutical Dosage Fonns, MARCEL DEKKER, INC., (1988), vol. 1, page 335 | - CONSTANTINIDES ET AL., PHARMACEUTICAL RESEARCH, (1994), vol. 11, pages 1385 - 1390 | - RITSCHEL, METH. FIND. EXP. CLIN. PHARMACOL., (1993), vol. 13, page 205 | - CONSTANTINIDES ET AL., PHARMACEUTICAL RESEARCH, (1994), vol. 11, page 1385 | - HO ET AL., J. PHANN. SCI., (1996), vol. 85, pages 138 - 143 | - LEE ET AL., CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, (1991), page 92 | - MURANISHI, CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, (1990), vol. 7, pages 1 - 33 | - EL HARIRI ET AL., J. PHARM. PHARMACOL., (1992), vol. 44, pages 651 - 654 | - BRUNTON ET AL., Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed.,, MCGRAW-HILL, (1996), pages 934 - 935 | - SWINYARD, Remington's Pharmaceutical Sciences, 18th Ed.,, MACK PUBLISHING CO., (1990), pages 782 - 783 | - YAMAMOTO ET AL., J. PHARM. EXP. THER., (1992), vol. 263, page 25 | - YAMASHITA ET AL., J. PHARM. SCI., (1990), vol. 79, pages 579 - 583 | - JARRETT, J. CHROMATOGR., (1993), vol. 618, pages 315 - 339 | - BUUR ET AL., J. CONTROL REL., (1990), vol. 14, pages 43 - 51 | - YAMASHITA ET AL., J. PHANN. PHARMACOL., (1987), vol. 39, pages 621 - 626 | - MIYAO ET AL., DSRNA RES. DEV., (1995), vol. 5, pages 115 - 121 | - TAKAKURA ET AL., DSRNA & NUCL. ACID DRUG DEV., (1996), vol. 6, pages 177 - 183 | US20080107998 |